Public-domain · open source
OpenJurist
← 194 F.2d 145 - Aktiebolaget Bofors v. United States

Aktiebolaget Bofors v. United States’s Empirical Analysis

194 F.2d 145 · 1951

Citation profile

81
cited by 81 later decisions
7
states following
June 2016
most recently cited

47 federal appellate · 9 district · 9 state decisions

How this case has been cited

Cited by 81 later decisions — most recently June 2016 · most notably Hyde Corporation v. Huffines (1958), Carter v. Seamans (1969)

47 federal appellate · 9 district · 9 state decisions

3101951196019701980199020002010decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Applies 22 U.S.C. § 411 · 28 U.S.C. § 1346 (Federal Tort Claims Act) · 28 U.S.C. § 1491 · 28 U.S.C. § 2680 · 5 U.S.C. § 1009

Relies on Larson v. Domestic & Foreign Commerce Corp. · A. O. Smith Corp. v. Petroleum Iron Works Co. · Peabody v. Norfolk · Booth v. Stutz Motor Car Co. of America, Inc.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 81 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. ““A breach of confidence under the rule stated in this Clause may also be a breach of contract which subjects the actor to liability under the rules stated in the Restatement of Contracts. But whether or not there is a breach of contract, the rule stated in this Section subjects the actor to liability if his disclosure or use of another’s trade secret is a breach of the confidence reposed in him by the other in disclosing the secret to him. The chief example of a confidential relationship under this rule is the relationship of principal and agent (see Restatement of Agency, Sections 395 and 396). Such is also the relationship between partners or other joint adventurers. But this confidence may exist also in other situations. For example, A has a trade secret which he wishes to sell with or without his business. B is a prospective purchaser. In the course of negotiations, A discloses the secret to B solely for the purpose of enabling him to appraise its value. Or, A requests a loan from B, a banker, for the purpose of aiding the manufacture of a product by A’s secret process. In order to assure B about the soundness of the loan, A discloses the secret to him in confidence. In both cases B is under a duty not to disclose the secret or use it adversely to A. * * *” 4 Restatement of Torts, Sec. 757, Comment on Clause (b) p. 13.”
    1 later decision quote this exact passage · from the majority
  2. “[O]ne who has lawfully acquired a trade secret may use it in any manner without liability unless he acquired it subject to a contractual limitation or restriction as to its use. In that event a licensee who uses the secret for purposes beyond the scope of the license granted by the owner is liable for breach of contract, but he commits no tort, because the only right of the owner which he thereby invades is one created by the agreement of disclosure. The owner could not maintain a suit against him for damages arising from unlicensed use without pleading and proving the contract. This being true, the gist of the owner's action is the breach of the licensing agreement.”
    1 later decision quote this exact passage · from the majority
  3. ““Even though a tort claim was not stated in the complaint, we should determine whether its allegations set up any other cause of action, for the label which a plaintiff applies to a pleading does not determine the nature of the cause of action which he states * * * ” p. 148.”
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.